Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

Discussing Karyopharm's Subgroup Analysis SIENDO Study in Patients with TP53 Wild Type Endometrial Cancer for Selinexor as Maintenance Therapy

Executed on:May 3, 2023 12:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Women's Cancer Care Associates
  • Gynecologic Oncologist at Women's Cancer Care Associates (NY) & Assistant Professor at Albany Medical College
  • Treats approximately 30 dMMR patients per year
  • Research focused on immunotherapy and clinical trials for ovarian and endometrial carcinoma.

Interview Goal

This conversation will focus on the potential of Karyopharm's  selinexor as a maintenance therapy for TP53 WT endometrial cancer patients.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.